Neurocrine Bioscience buy Needham & Company LLC
Start price
31.07.26
/
50%
€148.60
Target price
31.07.27
€177.24
Performance (%)
-11.94%
Price
13.08.26
€130.85
Summary
This prediction is currently active. The prediction for Neurocrine Bioscience disappoints with a performance of -11.94%. This prediction currently runs until 31.07.27. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -5.660% |
| iShares Core DAX® | 0,88 % |
| iShares Nasdaq 100 | 2,39 % |
| iShares Nikkei 225® | 4,27 % |
| iShares S&P 500 | 1,17 % |
Comments by Needham___Company_LL for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Needham & Company LLC from $200.00 to $204.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€113.60
06.04.26
06.04.26
€160.60
06.04.27
06.04.27
15.05%
13.08.26
13.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.40
22.09.25
22.09.25
€144.89
22.09.26
22.09.26
5.18%
13.08.26
13.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.35
06.05.25
06.05.25
€123.07
06.05.26
06.05.26
10.28%
07.05.26
07.05.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€86.30
15.04.25
15.04.25
€121.87
15.04.26
15.04.26
27.81%
16.04.26
16.04.26